부산대학교 도서관

Yang LY; Li CQ; Zhang YL; Ma MW; Cheng W; Zhang GJ

International Journal of Nanomedicine, Vol Volume 19, Pp 2591-2610 (2024)

Bai Y; Gao XS; Qin SB; Chen JY; Su MM; Liu Q; Qin XB; Ma MW; Zhao B; Gu XB; Xie M; Cui M; Qi X; Li XY

OncoTargets and Therapy, Vol Volume 11, Pp 2571-2579 (2018)

Bai Y; Gao XS; Qin SB; Chen JY; Su MM; Liu Q; Qin XB; Ma MW; Zhao B; Gu XB; Xie M; Cui M; Qi X; Li XY

OncoTargets and Therapy, Vol Volume 13, Pp 1185-1186 (2020)

Liu MZ; Department of Radiation Oncology, Peking University First Hospital, Beijing, China; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.; Chen JY; Department of Radiation Oncology, Peking University First Hospital, Beijing, China.; Lyu F; Department of Radiation Oncology, Peking University First Hospital, Beijing, China.; Gao XS; Department of Radiation Oncology, Peking University First Hospital, Beijing, China. Electronic address: doctorgaoxs@126.com.; Ma MW; Department of Radiation Oncology, Peking University First Hospital, Beijing, China.; Li XY; Department of Radiation Oncology, Peking University First Hospital, Beijing, China.; Li HZ; Department of Radiation Oncology, Peking University First Hospital, Beijing, China.; Qin SB; Department of Radiation Oncology, Peking University First Hospital, Beijing, China.; Gao Y; Department of Radiation Oncology, Peking University First Hospital, Beijing, China.; Wang PY; School of Information, University of Michigan, Ann Arbor, MI, USA.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Li YD; Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ma MW; Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Hassan MM; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, USA.; Hunkeler M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Teng M; Center for Drug Discovery, Department of Pathology & Immunology, and Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX, USA.; Puvar K; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Rutter JC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Lumpkin RJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Sandoval B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Jin CY; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Schmoker AM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Ficarro SB; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Blais Proteomics Center and Center for Emergent Drug Targets, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Cheong H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Metivier RJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Wang MY; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Xu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Byun WS; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, USA.; Groendyke BJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; You I; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, USA.; Sigua LH; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Tavares I; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Blais Proteomics Center and Center for Emergent Drug Targets, Dana-Farber Cancer Institute, Boston, MA, USA.; Zou C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Tsai JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Park PMC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Yoon H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Majewski FC; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, USA.; Sperling HT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Marto JA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Blais Proteomics Center and Center for Emergent Drug Targets, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Qi J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Nowak RP; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Słabicki M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Gray NS; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, USA. nsgray01@stanford.edu.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. eric_fischer@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. eric_fischer@dfci.harvard.edu.; Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. benjamin_ebert@dfci.harvard.edu.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. benjamin_ebert@dfci.harvard.edu.; Howard Hughes Medical Institute, Boston, MA, USA. benjamin_ebert@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101231976 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4469 (Electronic) Linking ISSN: 15524450 NLM ISO Abbreviation: Nat Chem Biol Subsets: MEDLINE

Ma MW; Department of Radiation Oncology, Peking University First Hospital, Beijing China.; Wang K; Department of Radiology, Peking University First Hospital, Beijing China.; Gao XS; Department of Radiation Oncology, Peking University First Hospital, Beijing China. Electronic address: doctorgaoxs@126.com.; Zhu TZ; Department of Radiology, Peking University First Hospital, Beijing China.; Li HZ; Department of Radiation Oncology, Peking University First Hospital, Beijing China.; Shen Q; Department of Urological Pathology, Peking University First Hospital, Beijing China.; Yang KW; Department of Urology, Peking University First Hospital, Beijing China.; Qiu JX; Department of Radiology, Peking University First Hospital, Beijing China. Electronic address: qjx761225@126.com.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Ma MW; Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China.; Wang ZS; Department of Radiation Oncology, Hebei Yizhou Proton Center, Zhuozhou, Hebei Province, 072750, China. Electronic address: wangzs0622@163.com.; Li HZ; Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China. Electronic address: doclee0134@163.com.; Gao XS; Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China. Electronic address: doctorgaoxs@126.com.; Liu C; Department of Radiation Oncology, Hebei Yizhou Proton Center, Zhuozhou, Hebei Province, 072750, China.; Ren XY; Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China.; Zhang WL; Department of Radiation Oncology, Hebei Yizhou Proton Center, Zhuozhou, Hebei Province, 072750, China.; Yang KW; Department of Urology, Peking University First Hospital, Beijing 100034, China.

Publisher: Elsevier Science Country of Publication: United States NLM ID: 8908862 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4022 (Electronic) Linking ISSN: 18734022 NLM ISO Abbreviation: Med Dosim Subsets: MEDLINE

Li HZ; Departments of Radiation Oncology and.; Qi X; Departments of Radiation Oncology and.; Gao XS; Departments of Radiation Oncology and. Electronic address: doctorgaoxs@126.com.; Li XM; Departments of Radiation Oncology and.; Qin SB; Departments of Radiation Oncology and.; Li XY; Departments of Radiation Oncology and.; Ma MW; Departments of Radiation Oncology and.; Bai Y; Departments of Radiation Oncology and.; Chen JY; Departments of Radiation Oncology and.; Ren XY; Departments of Radiation Oncology and.; Li XY; Medical Statistics, Peking University First Hospital, Peking University, Beijing, People's Republic of China.; Wang D; Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois. Electronic address: dian_wang@rush.edu.

Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

Liu MZ; Department of Radiation Oncology, Peking University First Hospital, No. 7 Xishiku Street, Beijing, 100034, China.; Li XY; Department of Radiation Oncology, Peking University First Hospital, No. 7 Xishiku Street, Beijing, 100034, China.; Lyu F; Department of Radiation Oncology, Peking University First Hospital, No. 7 Xishiku Street, Beijing, 100034, China.; Gao XS; Department of Radiation Oncology, Peking University First Hospital, No. 7 Xishiku Street, Beijing, 100034, China. doctorgaoxs@126.com.; Chen JY; Department of Radiation Oncology, Peking University First Hospital, No. 7 Xishiku Street, Beijing, 100034, China.; Gao Y; Department of Radiation Oncology, Peking University First Hospital, No. 7 Xishiku Street, Beijing, 100034, China.; Xie M; Department of Radiation Oncology, Peking University First Hospital, No. 7 Xishiku Street, Beijing, 100034, China.; Ren XY; Department of Radiation Oncology, Peking University First Hospital, No. 7 Xishiku Street, Beijing, 100034, China.; Ma MW; Department of Radiation Oncology, Peking University First Hospital, No. 7 Xishiku Street, Beijing, 100034, China. shandianmcqueen@163.com.

Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-8726 (Electronic) Linking ISSN: 07244983 NLM ISO Abbreviation: World J Urol Subsets: MEDLINE

Ma MW; Department of Radiation Oncology, Peking University First Hospital, No.7 Xishiku Street, Beijing, 100034, China.; Gao XS; Department of Radiation Oncology, Peking University First Hospital, No.7 Xishiku Street, Beijing, 100034, China. doctorgaoxs@126.com.; Zhang ZY; Philips Research China, Shanghai, 200072, China.; Shang SY; Department of Radiation Oncology, Peking University First Hospital, No.7 Xishiku Street, Beijing, 100034, China.; Jin L; Philips Research China, Shanghai, 200072, China.; Liu PL; Department of Radiation Oncology, Peking University First Hospital, No.7 Xishiku Street, Beijing, 100034, China.; Lv F; Department of Radiation Oncology, Peking University First Hospital, No.7 Xishiku Street, Beijing, 100034, China.; Ni W; Philips Research China, Shanghai, 200072, China.; Han YC; Philips Research China, Shanghai, 200072, China.; Zong H; Philips Research China, Shanghai, 200072, China.

Publisher: BioMed Central Country of Publication: England NLM ID: 101088682 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6947 (Electronic) Linking ISSN: 14726947 NLM ISO Abbreviation: BMC Med Inform Decis Mak Subsets: MEDLINE